Effects of leukapheresis protocol, cell processing and cryopreservation on the generation of monocyte-derived DC for immune therapy

scientific article published on 01 January 2003

Effects of leukapheresis protocol, cell processing and cryopreservation on the generation of monocyte-derived DC for immune therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/14653240310000056
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S1465324903711657?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:S1465324903711657?httpAccept=text/xml
P698PubMed publication ID12745589

P2093author name stringM. Nieda
A. J. Nicol
A. Maksoud
A. Tazbirkova
D. C. Horley
M. Okai
T. M. Crough
P2860cites workDendritic cells and the control of immunityQ27860918
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical applicationQ33536357
Dendritic cell based tumor vaccinesQ34038736
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanomaQ36375683
Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myelomaQ40629636
Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responsesQ40848632
Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.Q40865041
Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myelomaQ41044788
Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigenQ71931319
Dendritic cell-based immunotherapy for prostate cancerQ73489469
Freezing of dendritic cells, generated from cryopreserved leukaphereses, does not influence their ability to induce antigen-specific immune responses or functionally react to maturation stimuliQ73897603
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cellsQ74280070
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cellsQ74449986
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptidesQ74744883
Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanomaQ77357197
Comparison of COBE Spectra software version 4.7 PBSC and version 6.0 auto PBSC programQ77833904
Idiotypic protein-pulsed dendritic cell vaccination in multiple myelomaQ78202930
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectimmunologyQ101929
cell biologyQ7141
oncologyQ162555
immunotherapyQ1427096
P1104number of pages9
P304page(s)31-39
P577publication date2003-01-01
P1433published inCytotherapyQ5201399
P1476titleEffects of leukapheresis protocol, cell processing and cryopreservation on the generation of monocyte-derived DC for immune therapy
P478volume5

Reverse relations

Q50771098Monocyte enriched apheresis for preparation of dendritic cells (DC) to be used in cellular therapy.cites workP2860

Search more.